Potential Research Participants for Future Studies of Inherited Eye Diseases
Evaluation and Treatment Protocol for Potential Research Participants With Inherited Ophthalmic Diseases
2 other identifiers
observational
400
1 country
1
Brief Summary
This study will evaluate potential candidates for future clinical research studies related to diagnosed or undiagnosed genetic eye disorders or diseases. It will not test any new treatments, but it may arrange for standard treatments for existing eye disorders. The purpose of the study is to train eye doctors and medical researchers at the National Institutes of Health in appropriate methods and procedures for treating patients with genetic eye diseases, and to expand the pool of possible participants for future research studies and trials on eye health. Volunteers for this study may be adults and minor children who have been diagnosed with or are at risk for having a genetic eye disease. Candidates may not have any other medical conditions that would interfere with the researchers' ability to perform the examinations and procedures required for this study. Participants will give a complete medical and family history and undergo a series of tests and procedures as part of this research study. The procedures include a full eye examination and vision testing, electrooculography and an electroretinogram to examine the function of the retina, and flourescein angiography to provide information on the flow of blood in the participant's eyes. Participants will provide research material for further studies by giving a blood sample to be held for genetic testing and analysis, and adult participants will also undergo a skin biopsy to provide cell tissue for additional research material. At each clinic visit, participants will receive treatment for their genetic eye disease as needed, including medications or surgical procedures. Participants may remain a part of this study for up to three years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2007
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 9, 2007
CompletedFirst Submitted
Initial submission to the registry
November 15, 2007
CompletedFirst Posted
Study publicly available on registry
November 16, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2008
CompletedJuly 2, 2017
October 3, 2008
November 15, 2007
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Subjects will be able to enroll if they:
- Have either a diagnosed or undiagnosed genetic eye disease.
- Have the ability to understand and sign an informed consent or have a parent/legal guardian who is able to do so for them.
You may not qualify if:
- Subjects will not be eligible if they:
- Are unwilling or unable to be followed and treated at the NEI Clinical Center.
- Have any systemic diseases that compromise the ability to provide adequate ophthalmologic examination or treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (2)
MacDonald IM, Mah DY. Summary of heritable ocular disorders and selected systemic conditions with eye findings. Ophthalmic Genet. 2000 Mar;21(1):29-49.
PMID: 10779848BACKGROUNDMacDonald IM, Haney PM, Musarella MA. Summary of ocular genetic disorders and inherited systemic conditions with eye findings. Ophthalmic Genet. 1998 Mar;19(1):1-17. doi: 10.1076/opge.19.1.1.2181.
PMID: 9587925BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
November 15, 2007
First Posted
November 16, 2007
Study Start
November 9, 2007
Study Completion
October 3, 2008
Last Updated
July 2, 2017
Record last verified: 2008-10-03